Gloddek B, Gloddek J, Arnold W
Department of Otolaryngology/Head & Neck Surgery, Klinikum rechts der Isar der Technischen Universität München, Germany.
Ann N Y Acad Sci. 1997 Dec 29;830:266-76. doi: 10.1111/j.1749-6632.1997.tb51897.x.
Different patterns of sensorineural hearing loss with a potential improvement in auditory function following immunosuppressive therapy might be caused by an isolated autoimmune disease of the inner ear. Because of the lack of well-defined detection methods to identify autoimmune processes within the inner ear and the fact that the human inner ear is one of the few organs of the body not amenable to diagnostic biopsy, there has been great interest in developing animal models. Previous studies found evidence that this entity might be cellular mediated. By heterologeous immunization of inbred Lewis rats with inner-ear tissue, an autoreactive inner-ear-specific T-cell line was established. After passive transfer of these cells, a labyrinthitis was induced in recipient animals. The experimental design can serve as an animal model for a cellular-mediated autoimmune disease of the inner ear. Further studies have to split the cochlear proteins and to identify the protein with the strongest autoimmunological potency. After biotechnical production of this protein, a clinical test to diagnose an autoimmune disease of the inner ear in man should be possible.
免疫抑制治疗后出现不同模式的感音神经性听力损失且听觉功能有潜在改善,可能是由内耳孤立性自身免疫疾病引起的。由于缺乏明确的检测方法来识别内耳内的自身免疫过程,且人类内耳是人体少数不适合进行诊断性活检的器官之一,因此人们对开发动物模型产生了浓厚兴趣。先前的研究发现有证据表明该实体可能是细胞介导的。通过用内耳组织对近交系Lewis大鼠进行异种免疫,建立了一种自身反应性内耳特异性T细胞系。将这些细胞进行被动转移后,在受体动物中诱发了迷路炎。该实验设计可作为内耳细胞介导的自身免疫疾病的动物模型。进一步的研究必须分离耳蜗蛋白,并鉴定出自身免疫效力最强的蛋白。在通过生物技术生产这种蛋白后,应该有可能进行一项临床试验来诊断人类内耳的自身免疫疾病。